The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: December 2025

December 8, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.


6. The source of dietary fat influences anti-tumour immunity in obese mice

  • 1. Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage
  • 2. PPP2R1A mutations portend improved survival after cancer immunotherapy
  • 3. Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness
  • 4. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
  • 5. Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy
  • 6. The source of dietary fat influences anti-tumour immunity in obese mice
  • 7. Nerve-to-cancer transfer of mitochondria during cancer metastasis
  • 8. Stromal lipid species dictate melanoma metastasis and tropism
  • 9. TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
  • 10. IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages
Previous
Next
Kunkemoeller, B., Prendeville, H. et al. Nature Metabolism. 7: 1630–1645. (2025).
doi: 10.1038/s42255-025-01330-w.

Summary of the findings

Obesity is a major risk factor for many cancers. This is due in part to defective anti-tumour immune responses, caused by changes in systemic and cellular metabolism. While mouse models of diet induced obesity have revealed many mechanisms of immune dysfunction in obesity, most studies use only one fat source – lard. In this study, we examined how different dietary lipids impact tumour growth and shape the anti-tumour immune response in obesity.
.
To test this, mice were fed high-fat diets (HFD) derived from a variety of fat sources and later injected with B16 melanoma cells. While all HFDs resulted in significant weight gain, we found that tumour growth kinetics were dependent on the source of dietary fat. Tumours grew rapidly in mice fed butter-HFD but not mice fed palm oil-HFD, which had a similar growth pattern to mice fed a standard fat diet. These differences were reflected in the tumour immune landscape, where infiltration of Natural Killer (NK) cells was significantly reduced in mice fed butter-HFD, but not palm oil-HFD. Furthermore, IFNγ production by NK and CD8 T cells was defective in mice fed butter-HFD but not palm oil-HFD. These differences were driven by distinct effects on the plasma metabolome and intracellular metabolism. We identified stearoyl-carnitine (CAR18:0) as an immunosuppressive lipid metabolite enriched in the plasma of mice fed butter-HFD. CAR18:0 induced mitochondrial dysfunction and impaired IFNγ production in CD8 T cells, which blunted their cytotoxicity. While NK cells were resistant to the effects of CAR18:0, NK cells from mice fed butter-HFD accumulated intracellular lipids and could not elevate the rates of cellular metabolism in response to cytokine. Conversely, NK cells from mice fed palm oil-HFD maintained optimal lipid homeostasis and were protected from metabolic dysfunction, possibly through sustained cMyc activity.
.
.
Butter and palm oil-HFDs induce systemic metabolic dysfunction in mice. However, distinct effects on the plasma metabolome and cellular metabolism reveal that palm oil-HFDs are protective and butter-HFDs are more harmful to anti-tumour immunity in obesity.
.

Future impact

Our work demonstrates that diet shapes the anti-tumour immune response in obesity. Modifying dietary fat presents an affordable and promising strategy to improve cancer outcomes in obesity, by adjusting the metabolic milieu to promote an effective anti-tumour immune response. Future investigations may focus on the role of diet in the context of immunotherapy and may reveal particular dietary components or metabolites that maximise the benefits of immunotherapy.

…
Read more in Nature Metabolism
.

6. The source of dietary fat influences anti-tumour immunity in obese mice

  • 1. Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage
  • 2. PPP2R1A mutations portend improved survival after cancer immunotherapy
  • 3. Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness
  • 4. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
  • 5. Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy
  • 6. The source of dietary fat influences anti-tumour immunity in obese mice
  • 7. Nerve-to-cancer transfer of mitochondria during cancer metastasis
  • 8. Stromal lipid species dictate melanoma metastasis and tropism
  • 9. TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
  • 10. IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages
Previous
Next

 

Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

January 16, 2026

Our guest in this episode is Bernhard Küster, Professor at the Technical University of Munich, Director of the Bavarian Biomolecular Mass Spectrometry Center and Co-Director of...

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

December 10, 2025

René Bernards (EACR Past President) and Johanna Joyce (EACR President Elect), together with Michael Baumann and Anton Berns, have written a new commentary highlighting the urgent...

Research Focus: How Dietary Fats Shape Immune Defenses Against Cancer – Episode 27 of The Cancer Researcher Podcast

Research Focus: How Dietary Fats Shape Immune Defenses Against Cancer – Episode 27 of The Cancer Researcher Podcast

December 8, 2025

What you eat – specifically the type of fat – might matter for how well your immune system can fight cancer under conditions of obesity. In...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

“It is a journey rather than a race toward a single endpoint”: Interview with Ayelet Erez, winner of the 2026 Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award
Community

“It is a journey rather than a race toward a single endpoint”: Interview with Ayelet Erez, winner of the 2026 Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award

January 19, 2026
Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast
Features

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

January 16, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR